CAS 120202-71-3
:(R)-Clopidogrel bisulfate
Description:
(R)-Clopidogrel bisulfate is an antiplatelet medication primarily used to prevent blood clots in patients with cardiovascular diseases. It is a prodrug that requires metabolic activation to exert its therapeutic effects, specifically inhibiting the P2Y12 receptor on platelets, thereby preventing platelet aggregation. The compound is characterized by its chiral nature, with the (R)-enantiomer being the active form responsible for its pharmacological activity. Clopidogrel bisulfate is typically administered orally and is well-absorbed in the gastrointestinal tract, although its bioavailability is affected by first-pass metabolism. The substance is often formulated as a bisulfate salt to enhance its solubility and stability. Common side effects include bleeding complications, gastrointestinal disturbances, and, in rare cases, hypersensitivity reactions. Due to its mechanism of action, it is crucial for patients to be monitored for signs of bleeding, especially when used in conjunction with other anticoagulants or antiplatelet agents. Overall, (R)-Clopidogrel bisulfate plays a significant role in the management of thrombotic disorders.
Formula:C16H16ClNO2S·H2O4S
InChI:InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m1./s1
InChI key:InChIKey=FDEODCTUSIWGLK-XFULWGLBSA-N
SMILES:[C@@H](C(OC)=O)(N1CC2=C(CC1)SC=C2)C3=C(Cl)C=CC=C3.S(=O)(=O)(O)O
Synonyms:- (R)-(-)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate bisulfate
- (R)-(-)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate
- (R)-Clopidogrel bisulfate
- (R)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate
- Clopidogrel Related Compound C
- Methyl(-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate
- Sr 25989C
- Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αR)-, sulfate (1:1)
- methyl (2R)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate sulfate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
Clopidogrel Related Compound C (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO2S·H2SO4Color and Shape:White PowderMolecular weight:321.05903(R)-Methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7h)-yl)acetate sulfate
CAS:Formula:C16H18ClNO6S2Purity:97%Color and Shape:SolidMolecular weight:419.9002Clopidogrel EP Impurity C Sulfate (Clopidogrel USP Related Compound C, (R)-Clopidogrel Sulfate)
CAS:Formula:C16H16ClNO2S·H2SO4Color and Shape:White To Off-White SolidMolecular weight:321.82 98.07Clopidogrel Related Compound C
CAS:<p>Clopidogrel Related Compound C</p>Purity:≥95%Molecular weight:419.89g/molClopidogrel Related Compound C
CAS:<p>(R)-Clopidogrel bisulfate (Clopidogrel Related Compound C) is an isomer of clopidogrel. Clopidogrel is a P2Y12 receptor antagonist.</p>Formula:C16H18ClNO6S2Purity:97.84%Color and Shape:SolidMolecular weight:419.9R-(-)-Clopidogrel Hydrogen Sulfate
CAS:Controlled Product<p>Impurity Clopidogrel EP Impurity C<br>Stability Very Hygroscopic<br>Applications R-(-)-Clopidogrel Hydrogen Sulfate (Clopidogrel EP Impurity C) is used as an antithrombotic. Clopidogrel Related Compound C<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Mills, D.C.B., et al.: Arterioscler. Thromb., 12, 430 (1992), Feuerstein, G., et al.: Exp. Opin. Invest. Drugs, 4, 425 (1995)<br></p>Formula:C16H16ClNO2S·H2O4SColor and Shape:WhiteMolecular weight:419.90R-(-)-Clopidogrel hydrogen sulfate
CAS:<p>R-(-)-Clopidogrel hydrogen sulfate is a prodrug of clopidogrel, which is an antiplatelet agent. It is used to prevent thrombotic events in people with coronary artery disease, peripheral arterial disease, or cerebrovascular disease. The drug is broken down in the liver and then converted to an active form by the enzyme CYP2C19. The R-(-)-isomer of clopidogrel has been shown to be more effective for reducing platelet aggregation than its S-enantiomer, with no difference in effectiveness between the two forms for reducing heart attacks and strokes. This drug can be found in wastewater samples due to its use as a therapeutic agent. The method used for analysis was LC-MS/MS and the excipients were not reported.</p>Formula:C16H18ClNO6S2Purity:Min. 98 Area-%Color and Shape:White Slightly Yellow PowderMolecular weight:419.02641









